Genzyme Takes Income Hit On ‘Promising Drug’ License
by Worcester Business - October 22, 2008 11:00pm
Genzyme Corp., a Cambridge-based biotech and pharmaceutical company with significant operations in Central Massachusetts, said third quarter profits slipped to $120 million from $159 million for the same period last year.
More Worcester News